DME
Clinical trials for DME explained in plain language.
Never miss a new study
Get alerted when new DME trials appear
Sign up with your email to follow new studies for DME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New daily pill aims to ease diabetic eye swelling
Disease control Not yet recruitingThis study tests an experimental daily pill (CU06-1004) for people with diabetic macular edema, a condition that causes vision loss from fluid buildup in the eye. About 156 adults will take either a low dose, high dose, or a placebo for 24 weeks. The main goal is to see if the pi…
Matched conditions: DME
Phase: PHASE2 • Sponsor: Curacle Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:48 UTC
-
New hope for diabetic eye disease: experimental drug SNP318 enters Mid-Stage trial
Disease control Not yet recruitingThis study tests an experimental drug called SNP318 in 60 people with diabetic macular edema (DME), a condition that causes vision loss due to swelling in the retina. The goal is to see if the drug is safe and can improve vision or reduce swelling compared to a placebo. Participa…
Matched conditions: DME
Phase: PHASE2 • Sponsor: SciNeuro • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
AI eye doctor: QiLin system aims to sharpen injection decisions
Knowledge-focused Not yet recruitingThis study tests an artificial intelligence system called QiLin that helps doctors decide when to give anti-VEGF injections for retinal diseases like wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. About 200 patients who have completed in…
Matched conditions: DME
Phase: NA • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 11:53 UTC